Atlas Trials

Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects

Clinical trial NCT02992418 · TERMINATED

Trial details

NCT number
NCT02992418
Sponsor
Sanofi Pasteur, a Sanofi Company
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Dengue FeverDengue Hemorrhagic Fever
Start date
2016-12-19
Primary completion
2019-12-10
Enrollment
688

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.